8 INVESTIGATES: Comparing the 3 vaccines in the U.S.

Medical officials say this is a win in the fight against COVID-19 because the Johnson and Johnson vaccine is one shot and can be refrigerated, not stored in subzero temps like the Moderna and Pfizer.

LINCOLN, Neb. (KLKN)- When it comes to efficacy the Johnson and Johnson vaccine is 66 percent effective symptomatic disease and 85 percent effective against most severe cases of COVID –19 in a massive study that spanned three continents.
This comes after the vaccine was recommended on Friday and passed Saturday by the FDA for emergency use authorization. Medical experts say the new vaccine offers strong protection against what matters the most, serious illness, hospital stays, and death.
The Johnson and Johnson vaccine is cleared for adults 18 and up. In comparison, Pfizer is 95 percent and Moderna is 94.5 against symptomatic disease.
SEE ALSO: US panel endorses 3rd vaccine option from J&J

Medical officials say this is a win in the fight against COVID-19 because the Johnson and Johnson vaccine is one shot and can be refrigerated, not stored in subzero temps like the Moderna and Pfizer.
According to an FDA report in late February, side effects from the Johnson and Johnson vaccine appear to be milder than Pfizer and Moderna’s side effects. Common side effects of the Johnson and Johnson vaccine are headache, fatigue, injection site pain, or pain in the muscles (myalgia).
Officials say as many as 4 million doses of the new Johnson and Johnson vaccine could be shipped as early as today, March 1st.

MORE: Johnson & Johnson vaccine unanimously recommended for Emergency Use Authorization

Governor Ricketts’ talks Johnson & Johnson vaccine

 

 

 

Categories: Coronavirus, News